Scripps Md Anderson - Prebys Cancer Center /ID# 276891 — San Diego, California

Scripps Md Anderson - Prebys Cancer Center /ID# 276891 is a clinical research site located in San Diego, California, United States 92103.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Scripps Md Anderson - Prebys Cancer Center /ID# 276891 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Diego

Browse all research sites in California · View every site in San Diego

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scripps Md Anderson - Prebys Cancer Center /ID# 276891?

Scripps Md Anderson - Prebys Cancer Center /ID# 276891 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scripps Md Anderson - Prebys Cancer Center /ID# 276891 conducted?

Scripps Md Anderson - Prebys Cancer Center /ID# 276891 has 2 clinical trials on record, with 2 currently active. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Scripps Md Anderson - Prebys Cancer Center /ID# 276891 accredited by Crixeo Clinical Trials?

Scripps Md Anderson - Prebys Cancer Center /ID# 276891 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Scripps Md Anderson - Prebys Cancer Center /ID# 276891?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.